RCON vs PLRX
Comparison between Recon Technology Ltd - Class A (RCON, Company) and Pliant Therapeutics Inc (PLRX, Company).
RCON is from the Energy sector, while PLRX is from the Healthcare sector.
5-Year PerformancePLRX has outperformed RCON, delivering a return of -46.8% compared to -62.5%
RCON vs PLRX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
RCON vs PLRX - Historical Returns
Returns include dividend reinvestment.
RCON vs PLRX - Annual Returns (2009 - 2026)
Returns include dividend reinvestment.
| Year | RCON | PLRX |
|---|---|---|
| 2026 | -72.77% | -13.60% |
| 2025 | -26.51% | -90.81% |
| 2024 | -50.12% | -26.67% |
| 2023 | -81.47% | -4.68% |
| 2022 | -8.70% | +37.09% |
| 2021 | -12.08% | -44.94% |
| 2020 | -48.96% | +6.67% |
| 2019 | -36.33% | N/A |
| 2018 | -44.74% | N/A |
| 2017 | -2.26% | N/A |
| 2016 | -2.99% | N/A |
| 2015 | -29.59% | N/A |
| 2014 | -37.06% | N/A |
| 2013 | +115.41% | N/A |
| 2012 | +311.76% | N/A |
| 2011 | -93.47% | N/A |
| 2010 | -28.35% | N/A |
| 2009 | +19.93% | N/A |
RCON vs PLRX Drawdown Comparison
The maximum drawdown for RCON was -99.96%, occurring on Jun 24, 2026. This drawdown has not yet recovered.
The maximum drawdown for PLRX was -97.34%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current RCON drawdown is -99.95%. The current PLRX drawdown is -97.32%.
| Rank | RCON | PLRX |
|---|---|---|
| #1 | -99.96% Sep 23, 2009 - Jun 24, 2026 | -97.34% Mar 25, 2021 - Jul 20, 2026 |
| #2 | -32.06% Aug 5, 2009 - Sep 14, 2009 | -43.59% Jun 29, 2020 - Feb 24, 2021 |
| #3 | -1.70% Sep 16, 2009 - Sep 22, 2009 | -21.34% Feb 24, 2021 - Mar 25, 2021 |
| #4 | -1.64% Sep 14, 2009 - Sep 16, 2009 | -5.82% Jun 4, 2020 - Jun 15, 2020 |
| #5 | N/A | -2.53% Jun 15, 2020 - Jun 17, 2020 |
| #6 | N/A | -0.04% Jun 19, 2020 - Jun 23, 2020 |
Correlation
Correlation between RCON and PLRX is 0.56 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks